Abstract
Abstract
The thalassemia screening program in Indonesia mostly conducted sporadically. Ideal prospective screening is still limited. This study aimed to compare thalassemia screening methods using the extended family approach with and without a history of severe thalassemia and the feasibility of implementing extended family screening method. A case control study was conducted in Dr. Hasan Sadikin General Hospital Bandung with 3 generations of extended families. Data were collected from 150 subjects of 8 extended families with severe thalassemia as an index case entry and 151 subjects of 12 families with no history of thalassemia. All subjects were examined for Hb, MCV, MCH, and peripheral blood smear (PBS) as initial laboratory examinations. Subjects with MCV < 80 fL, MCH < 27 pg, and suggestive findings on PBS continued hemoglobin analysis. Carrier status was determined by definition. All subjects consented to undergo screening and voluntarily participated. The proportion of thalassemia carriers and the participation rate between the 2 groups were compared. Sixty-four of 150 (42.7%) and 16 of 151 (10.6%) carriers were identified in both the case and control group (p < 0.001). The participation rate was 42–88 vs. 23–100% (p = 0.244). The mean age was 31.9 ± 21.2 vs. 31.1 ± 20.8 years (p = 0.782). The median family size was 28.5 vs. 20 subjects per family (p = 0.245). The types of identified thalassemia carrier in both groups consisted of β-thalassemia, β-thalassemia/HbE, suspected α-thalassemia, and β-thalassemia Hb variant. All carriers continued the counseling process. The extended family method seems feasible to be implemented for thalassemia screening in West Java, Indonesia.
Funder
indonesia ministry of health
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Public Health, Environmental and Occupational Health,Epidemiology
Reference34 articles.
1. Ahmed S, Saleem M, Modell B, Petrou M (2002) Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 347(15):1162–1168. https://doi.org/10.1056/NEJMsa013234
2. Angastiniotis M, Eleftheriou A, Galanello R, Harteveld CL, Petrou M, Trager-Synodinos J (2013) Prevention of thalassaemias and other hemoglobin disorders: volume 1: principles. In: Old J, 2nd edn. Thalassaemia International Federation, Nicosia (Cyprus).
3. Ansari SH, Baig N, Shamsi TS, Saif-ur-Rehman AZH, Behar Z et al (2012) Screening immediate family members for carrier identification and counseling: a cost-effective and practical approach. J Pak Med Assoc 62(12):1314–1317
4. Baig SM, Din MA, Hassan H, Azhar A, Baig JM, Aslam M et al (2008) Prevention of beta-thalassemia in a large Pakistani family through cascade testing. Community Genet 11(1):68–70. https://doi.org/10.1159/000111641
5. Brock JA, Allen VM, Keiser K, Langlois S (2010) Family history screening: use of the three generation pedigree in clinical practice. J Obstet Gynaecol Can 32(7):663–672. https://doi.org/10.1016/s1701-2163(16)34570-4
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献